Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
about
Topoisomerase IIalpha gene (TOP2A) amplification and deletion in cancer--more common than anticipatedEnhanced etoposide sensitivity following adenovirus-mediated human topoisomerase IIalpha gene transfer is independent of topoisomerase IIbetaUse of a rapid throughput in vivo screen to investigate inhibitors of eukaryotic topoisomerase II enzymesTopoisomerase II alpha expression and the benefit of adjuvant chemotherapy for postoperative patients with non-small cell lung cancer.Assessment of Topoisomerase II α status in breast cancer by quantitative PCR, gene expression microarrays, immunohistochemistry, and fluorescence in situ hybridization.HER-2/neu and topoisomerase IIalpha in breast cancer.XK469, a selective topoisomerase IIbeta poison.Amsacrine as a topoisomerase II poison: importance of drug-DNA interactions.Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer.Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer.Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin.DNA topoisomerase IIalpha and -beta expression in human ovarian cancerDNA topoisomerase IIalpha expression and the response toprimary chemotherapy in breast cancer.Cytotoxicity of rhein, the active metabolite of sennoside laxatives, is reduced by multidrug resistance-associated protein 1Mitoxantrone resistance in a small cell lung cancer cell line is associated with ABCA2 upregulation.Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinoma.Establishment and characterization of 6-[[2-(Dimethylamino)ethyl]amino]-3-hydroxy-7H-indeno[2,1-c]quinolin-7-one dihydrochloride (TAS-103)-resistant cell lines.Expression of DNA topoisomerase II-α: Clinical significance in laryngeal carcinoma.Topoisomerase II-alpha expression in different cell cycle phases in fresh human breast carcinomas.High topoisomerase IIalpha expression associates with high proliferation rate and and poor prognosis in oligodendrogliomas.
P2860
Q28186346-3A67D9F7-397E-4538-A6EE-A29D3596E6EEQ28348262-EE6B037F-0845-415A-BCB1-5775483A633CQ33692759-B0290677-9E6A-447C-8B3F-0D20212BD810Q33743596-0A4511E9-F282-40AD-B9EE-5DF81BFCC5F0Q34805496-0E87A24A-C44A-480A-A632-4E61D2C771DCQ35130680-534DEDDE-2CE4-4D57-914D-D081A1FD3C7AQ35736271-A0A2229B-0468-4D30-BC67-42F9DD6AF7D0Q35788447-17586BFD-C42C-4641-B5AB-DD03833FACBCQ35809752-2B928F57-A385-42FF-90EC-2E2B1FC42D42Q36293034-C32ED483-5ED5-4D3B-ACC2-0D2A8BAC05D9Q36618801-08ADEC69-F086-450A-B76A-D62ECC2A9A2FQ36618975-CD5DE06A-C91A-4E77-B56C-B2EE3352B9C1Q36648223-CB31A368-CA49-45B5-998E-7E17A40D1257Q38283206-8B73B9C0-8593-4730-8D1E-AA560534BE8FQ38796029-6AA5CDBA-DB2D-48CF-89EA-55D276099B5EQ40595102-78400F97-0538-4DD0-A8AA-4674528E25EAQ40876344-9768BA24-6BB2-4033-9D4A-A8DCB7A7B201Q42865558-4FBB5B5C-BDEC-4959-B0CA-05DB5401975EQ43993916-4EF7F29D-D9E8-4869-9D41-414BD4460822Q49142324-4B6D2EEA-B723-4063-A30E-3CD035CE130A
P2860
Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Differential expression of DNA ...... the human SCLC cell line GLC4.
@en
type
label
Differential expression of DNA ...... the human SCLC cell line GLC4.
@en
prefLabel
Differential expression of DNA ...... the human SCLC cell line GLC4.
@en
P2093
P2860
P4510
P356
P1476
Differential expression of DNA ...... the human SCLC cell line GLC4
@en
P2093
E F Nienhuis
N H Mulder
W T van der Graaf
P2860
P2888
P304
P356
10.1038/BJC.1996.647
P407
P577
1996-12-01T00:00:00Z